It was a pleasure to define with the experts of Task Force Healthcare and successful entrepreneur in international markets Willem van Prooijen, some valuable and practical improvements to HemoClear’s international business strategy. Through this strategy, HemoClear will offer an innovative solution for the global transfusion blood shortage by making high-quality and affordable autologous transfusion blood available for those in need.
